Elizabeth Roper, a Partner at Epidarex Capital, invests in early-stage life science opportunities across biotechnology. See sector focus and contact routes.
Elizabeth Roper, a Partner at Epidarex Capital, invests in early-stage life science opportunities across biotechnology, pharmaceuticals, medical devices, and health tech, typically providing seed or Series A funding with a historical average check size of $5.8M. Her distinctive thesis prioritizes disruptive platform technologies in under-ventured US and UK research hubs that address unmet medical needs and possess robust intellectual property. Notable portfolio companies include Dunad Therapeutics, Nodthera (an Alzheimer’s biotech), Leucid Bio, Kynos Therapeutics, and Apellis Pharmaceuticals.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find comparable investors.
Investors like Elizabeth Roper · Full investor directory · Investor access · Company funding database